International news 4:33 p.m. 2023-12-15
The White House said Thursday (Dec. 14) that Sanofi and AstraZeneca (AstraZeneca) plans to deliver an additional 230,000 doses of respiratory syncytial virus (RSV) vaccine to infants in January. 2024 after US officials held discussions with both companies about winter vaccine delivery.
Sanofi said in a statement: The company will deliver a total of 1.4 million doses of its vaccine to the U.S. this year. This is 25% more than initially expected.
Officials from US President Joe Biden’s administration have held regular meetings with Sanofi and AstraZeneca. to jointly develop an RSV vaccine for infants and toddlers called Beyfortus.
Reuters reports that RSV is a virus that can cause acute respiratory infections in people of all ages. When most infants and children are infected There will be slight symptoms. It’s like having a cold. But for some babies Especially in children who are infected for the first time. The virus can cause lower respiratory tract diseases such as pneumonia and bronchiolitis.
According to the American Academy of Pediatrics, approximately 1-3% of babies under 12 months of age in the United States are born sick each year. Got sick and had to be hospitalized because of RSV infection.
The White House said: The announcement of the delivery of 230,000 vaccine doses came after officials met with Sanofi and AstraZeneca on Wednesday, building on an earlier agreement at An additional 77,000 vaccine doses will be procured.
By InfoQuest News Agency (15 Dec. ’23)
Tags: RSV, Sanofi, RSV vaccine, AstraZeneca
2023-12-15 10:10:21
#SanofiAstraZeneca #prepares #deliver #doses #RSV #vaccine #infants #United #States #InfoQuest
